CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Grant or award Director acquired 454 shares (grant or award)
- 4 Grant or award Director acquired 454 shares (grant or award)
- 4 Grant or award Director acquired 454 shares (grant or award)
- 4 Grant or award Director acquired 454 shares (grant or award)
- 4 Grant or award Director acquired 404 shares (grant or award)
- 4 Grant or award Director acquired 1,816 shares (grant or award)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Shareholder vote results
- 4 Planned sale Chief Medical Officer sold 1,042 shares at $495.74 ($516,561)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 5,682 shares at an average $515.44 ($2,928,716)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Medical Officer sold 844 shares at $515.90 ($435,420)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- ARS Other Annual Report to Security Holders
Page 2 of 62 · 1,224 filings